BridgeMD
New treatment option for Child Abuse Sexual
Official title ReDirection - Self Help Program for Individuals with Sexual Interest in Children
ClinicalTrials.gov ID: NCT06133569
What this study is testing
- What it's testing
- The overall aim of the study is to evaluate the effectiveness of the ReDirection program for individuals with low or medium risk to commit child sexual abuse. Primary question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Sufficient language skills: English, Swedish, Finnish, Czech, Slovak, German, or Spanish
- concern about sexual interest regarding children\ ,
- CSAM use past six month
- Low to medium risk for committing child sexual abuse according to the SChiMRA scale
You likely can't join if
- \- Participants with a severe psychiatric illness (such as high acute suicide risk or severe substance abuse) will be excluded, or lack of serious...
The study team makes the final eligibility decision.
Where it's taking place
- Klecany, Czechia
- Helsinki, Finland
- Hamburg, Germany
- Bratislava, Slovakia
- Castelló, Spain
- Stockholm, Sweden
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Klecany, Czechia; Helsinki, Finland; Hamburg, Germany; Bratislava, Slovakia; Castelló, Spain; Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.